Tetragon Biosciences Ltd
1 clinical trials · Sponsor
◉ Watch Tetragon Biosciences Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma (NCT07464925) | Tetragon Biosciences Ltd | 2026-04-20 |
Track Tetragon Biosciences Ltd automatically
Every clearance here is in the API, with alerts when new ones post.